Showing results (61-70 of 137) with videos related to
Sort By:
Pageof 14
Current Drug Safety|April 11, 2015
Teaching vaccine safety communication to medical students and health professionalsBarbara Rath, Susann Muhlhans, Gerhard GaedickeExpert Review of Respiratory Medicine|August 5, 2024
Overcoming resistance in small-cell lung cancerGerhard Hamilton, Maximilian J Hochmair, Sandra SticklerCancers|November 12, 2013
Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen SuppressionGerhard Hamilton, Ulrike Olszewski-Hamilton, Gerhard TheyerOncology Research|July 26, 2024
Development of PROTACS degrading KRAS and SOS1Gerhard Hamilton, Marie-Therese Eggerstorfer, Sandra SticklerCurrent Drug Safety|April 11, 2015
Vaccine safety monitoring systems in developing countries: an example of the Vietnam modelMohammad Ali, Barbara Rath, Vu Dinh ThiemJournal of Experimental Pharmacology|May 18, 2016
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cellsUlrike Olszewski, Ernst Ulsperger, Klaus Geissler, et al.Open Access Journal of Urology|November 8, 2013
Measurement of bone turnover in prostate cancer patients receiving intermittent androgen suppression therapyGerhard Theyer, Stefan Holub, Ulrike Olszewski, et al.Lung Cancer (Auckland, N.Z.)|February 18, 2017
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cellsUlrike Olszewski, Robert Zeillinger, Klaus Geissler, et al.Neoplasia (New York, N.Y.)|September 29, 2012
Alterations of phosphoproteins in NCI-H526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene YUlrike Olszewski, Anthony Deally, Matthias Tacke, et al.Current Drug Safety|April 11, 2015
Communicating vaccine safety to the media and general publicHiba Oubari, Ryan Tuttle, Barbara Rath, et al.Pageof 14